Qube Research & Technologies (QRT)
LGND icon

Qube Research & Technologies (QRT)’s Ligand Pharmaceuticals LGND Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-47,659
Closed -$9.52M – 3818
2026
Q1 		$9.52M Buy
47,659
+32,266
+210% +$6.38M 0.01% 1306
2025
Q4 		$2.91M Buy
15,393
+11,761
+324% +$2.26M ﹤0.01% 2066
2025
Q3 		$643K Sell
3,632
-14,453
-80% -$2.15M ﹤0.01% 2648
2025
Q2 		$2.06M Buy
18,085
+13,035
+258% +$1.39M ﹤0.01% 2183
2025
Q1 		$531K Buy
+5,050
New +$571K ﹤0.01% 2523
2024
Q2 		– Sell
-79
Closed -$5.78K – 4342
2024
Q1 		$5.78K Sell
79
-14,580
-99% -$1.07M ﹤0.01% 3872
2023
Q4 		$1.05M Sell
14,659
-25,595
-64% -$1.51M ﹤0.01% 1895
2023
Q3 		$2.41M Buy
40,254
+24,610
+157% +$1.62M 0.01% 1281
2023
Q2 		$1.13M Buy
15,644
+10,396
+198% +$780K ﹤0.01% 1257
2023
Q1 		$386K Buy
5,248
+1,481
+39% +$105K ﹤0.01% 1654
2022
Q4 		$252K Sell
3,767
-9,092
-71% -$591K ﹤0.01% 1715
2022
Q3 		$691K Sell
12,859
-20,597
-62% -$1.21M ﹤0.01% 1339
2022
Q2 		$1.86M Buy
33,456
+21,499
+180% +$1.22M 0.01% 849
2022
Q1 		$839K Buy
+11,957
New +$868K 0.01% 1255
2020
Q3 		– Sell
-24,795
Closed -$1.73M – 1933
2020
Q2 		$1.73M Buy
+24,795
New +$1.57M 0.03% 698

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LGND Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Ligand Pharmaceuticals (LGND) in Q2 2026, closing a stake of 47,659 shares — an estimated $9.52M sold.

Qube Research & Technologies (QRT) first reported a position in LGND in Q2 2020 and held it in 15 quarters. The position peaked at $9.52M in Q1 2026. 416 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Ligand Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 47,659 Ligand Pharmaceuticals shares in Q2 2026, an estimated $9.52M.
  • Qube Research & Technologies (QRT) first reported a position in Ligand Pharmaceuticals in Q2 2020 and held it in 15 quarters.
  • Qube Research & Technologies (QRT)'s Ligand Pharmaceuticals position peaked at $9.52M in Q1 2026.
  • 416 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.